scholarly journals Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial

2019 ◽  
Vol 21 (10) ◽  
pp. 2284-2293 ◽  
Author(s):  
Kohei Kaku ◽  
Hiroyuki Isaka ◽  
Taishi Sakatani ◽  
Junko Toyoshima
2019 ◽  
Vol 22 (3) ◽  
pp. 365-372 ◽  
Author(s):  
Thomas C. Blevins ◽  
Abhijit Barve ◽  
Yaron Raiter ◽  
Patrick Aubonnet ◽  
Sandeep Athalye ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document